The study of toxicokinetics and pharmacokinetics plays a crucial role in drug development and safety assessment.
Creative Bioarray offers a wide range of related resources, which allow researchers to evaluate the
pharmacokinetic properties of drugs and assess their potential toxicity.
Tag: Bioanalysis
Details: A technical guide focusing on the scientific rigors of quantifying drug concentrations in biological matrices and ensuring regulatory alignment.
Tag: Bioanalysis
Details: A masterclass in preventing ex vivo degradation, covering structural "red flags," the chemistry of enzymatic inhibition, and precise "bench-to-injection" thermal workflows.
Tag: Bioanalysis
Details: This technical resource identifies the primary causes of bioanalysis errors and assay validation problems, offering experienced-based strategies to resolve LC-MS issues and ensure method robustness during drug development.
Tag: Biomarkers
Details: A comprehensive guide to biomarker types and their role in drug discovery, highlighting how biomarker-driven strategies improve preclinical research and clinical success.
Tag: Biomarkers
Details: A comprehensive overview of biomarker validation methods in drug development, covering molecular, imaging, and multi-omics biomarkers, as well as analytical and clinical validation strategies, regulatory considerations, and emerging AI-driven approaches for precision medicine.
Tag: Biomarkers
Details: A deep dive into bridging the translational gap between target engagement and biological outcome to de-risk IND-enabling studies. It provides strategic insights for R&D leaders on synchronizing molecular data with functional efficacy to ensure clinical success.
Tag: Drug Toxicity
Details: A practical guide to troubleshooting common issues in drug toxicity testing, including assay variability, model limitations, and drug exposure challenges in preclinical studies.
Tag: Drug Toxicity
Details: Discover key drug toxicity types and modern preclinical approaches to evaluate liver, kidney, heart, and other organ risks for safer drug development.
Tag: Preclinical Toxicology
Details: A comprehensive overview of the preclinical workflow for drug toxicity testing, covering in vitro screening, in vivo toxicology studies, safety pharmacology, and GLP-compliant safety evaluation before clinical trials.
Tag: Drug Toxicity
Details: Learn how strategic preclinical toxicity design and CRO expertise help identify risks, improve safety, and accelerate drug development success.
Tag: Drug Toxicity
Details: A comparative overview of 2D and 3D cell culture models for drug toxicity assessment, highlighting their applications, advantages, and roles in improving preclinical safety prediction.
Tag: Drug Metabolism, CYP Phenotyping
Details: A guide to the 8 common CYP phenotyping mistakes and how to fix them, improving ADME data, predicting DDIs, and accelerating preclinical drug development.
Tag: Drug Metabolism
Details: A concise comparison of Metabolic Stability and Reaction Phenotyping, highlighting their distinct purposes in drug development and providing clear guidance on when to apply each assay.
Tag: Drug Metabolism, CYP Phenotyping
Details: Step-by-step guidance on interpreting CYP phenotyping results to support DDI risk assessment and development decisions.
Tag: Drug Metabolism, CYP Phenotyping
Details: A practical guide explaining the purpose, methods, and application of CYP reaction phenotyping in drug development for effective DDI risk assessment.
Tag: ADME
Details: A practical 6-step workflow for planning, executing, and interpreting in vitro ADME assays to support early drug discovery and informed compound selection.
Tag: ADME
Details: A stage-based ADME-Tox strategy highlighting key risk signals and integrated safety, PK, and potency insights to support better development decisions.
Tag: ADME
Details: In vitro ADME assays are key to early drug discovery-but poor design can mislead project decisions. Learn the five critical pitfalls, from model selection to concentration choices, and see how to turn your ADME data into actionable insights.
Tag: ADME
Details: A concise comparison of in vitro and in vivo ADME studies, explaining their respective roles, limitations, and how to use them together to support confident drug development decisions.
Tag: ADME
Details: A practical guide to selecting the right in vitro ADME assays for small-molecule drug discovery, aligned with development stage, physicochemical properties, and translational decision-making.
Tag: Genotoxicity
Details: Explore the molecular mechanisms behind genotoxicity and understand why assessing genetic risk is essential for safe drug discovery.
Tag: Genotoxicity
Details: A practical overview of genotoxicity assays, regulatory considerations, and data interpretation for researchers and drug developers.
Tag: Disease model
Details: An overview of disease modeling strategies, applications, and major challenges in preclinical research.
Tag: Cardiotoxicity
Details: Explore the most widely used cardiotoxicity testing methods—including in vitro assays, in vivo models, and advanced imaging.
Tag: Cardiotoxicity
Details: Discover what cardiotoxicity is, the key biological mechanisms behind it, and why evaluating cardiotoxic risks is essential in modern drug development and safety testing.
Tag: Toxicokinetic
Details: This article briefly explores toxicokinetics studies from aspects such as dose selection, matrix selection, choice of animal models, and sample collection
Tag: Drug Screening
Details: Organ-on-a-chip systems are poised to play an instrumental role in the future of drug screening by offering more reliable and comprehensive models of human physiology.
Tag: PK
Details: An array of strategies, such as amino acid substitution, side chain modifications, conjugation with polymers, modification of peptide termini, fusion to albumin, conjugation to the Fc portion of antibodies, stapled peptides, etc., have been employed to enhance the pharmacokinetic profiles of peptides.
Tag: PK
Details: The pharmacokinetic profile of therapeutic peptides significantly influences their therapeutic efficacy and safety. Key aspects of peptide pharmacokinetics include absorption, distribution, metabolism, and elimination.
Tag: DMPK
Details: This article described various drug delivery and targeting strategies are currently being developed to enhance the transport and distribution of drugs into the brain.
Tag: DMPK
Details: The distribution of drugs can be significantly affected by distinct brain characteristics such as anatomy, physiological barriers, and cellular and biochemical composition.
Tag: DMPK
Details: Drug distribution depends upon a range of variables such as the drug’s physicochemical composition, circulation, tissue content and how the drug interacts with macromolecules in the body.
Tag: In Vitro Testing
Details: The landscape of drug development has evolved significantly over the past few decades, with in vitro testing becoming increasingly integral to the process.
Tag: Antibody Drug Conjugates
Details: Antibody-drug conjugates (ADCs) represent a significant advancement, merging the specificity of monoclonal antibodies with the potency of cytotoxic drugs.
Tag: Antibody Drug Conjugates
Details: Understanding the pharmacokinetics (PK) of ADCs is crucial for optimizing their therapeutic efficacy while minimizing systemic toxicity.
Tag: In Vitro Permeability and Transporters
Details: Both MDCK-MDR1 and Caco-2 cell models have distinct advantages and limitations that impact their utility in drug discovery and development.
Tag: Bioavailability
Details: Bioavailability refers to the relative amount and speed with which a drug or other active substance reaches the systemic circulation and exerts its effect at the site of action after non-intravenous administration.
Tag: PK properties
Details: Oligonucleotide therapeutics are a class of nucleic acid-based treatments that exert therapeutic effects by binding to specific RNA or DNA molecules, thereby regulating gene expression or modifying gene activity.
Tag: Drug-drug interactions
Details: When two or more drugs are co-administered, their metabolic pathways can intersect, leading to a phenomenon known as metabolism-mediated drug-drug interactions (MMDDIs).
Tag: PK
Details: PK models can range in complexity from models with a single compartment to models containing hundreds of compartments.
Tag: Drug cytotoxicity
Details: Cytotoxicity assays are a quick way to assess a certain chemical compound’s effects on a given human cell line. Cytotoxicity experiments are a crucial part of the modern pharmaceutical development process.
Tag: Drug delivery
Details: The blood-brain barrier (BBB) is a highly selective and impermeable barrier that separates the circulatory system from the brain and the central nervous system (CNS).
Tag: Drug delivery
Details: Effective drug delivery is the cornerstone of modern pharmaceutical science, ensuring that therapeutic agents reach their intended targets within the body while minimizing adverse effects and optimizing therapeutic efficacy.
Tag: DMPK
Details: Plasma stability is a crucial parameter in drug development that refers to the ability of a drug molecule to maintain its structural integrity and pharmacological activity when exposed to the complex biological environment of the plasma.
Tag: Drug toxicity
Details: In the realm of drug discovery and development, the assessment of hERG (human Ether-à-go-go-Related Gene) channel toxicity plays a vital role.
Tag: Drug discovery
Details: Organoids provide a powerful tool for studying human biology and disease in a more physiologically relevant and predictive manner.
Tag: DMPK
Details: Through various methods, PAMPA has been employed to assess gastrointestinal permeability (GIT-PAMPA), skin permeability (skin-PAMPA), and blood-brain barrier permeability (BBB-PAMPA).
Tag: DMPK
Details: The importance of in vitro permeability assays lies in their ability to assess the ability of drug compounds to permeate cellular and tissue barriers, such as the intestinal epithelium or the blood-brain barrier.
Tag: Drug-drug interactions
Details: Cytochrome P450 enzymes can be inhibited or induced by drugs, resulting in clinically significant drug-drug interactions that can cause unanticipated adverse reactions or therapeutic failures.
Tag: Drug-drug interactions
Details: Metabolism-mediated drug-drug interactions can significantly affect drug efficacy and safety, and thus it is imperative to identify and comprehend them during the drug development phase.
Tag: Drug toxicity
Details: Predicting the potential toxicity of new drug candidates is a critical step in the drug discovery and development process.
Tag: Drug properties
Details: In the realm of drug discovery and development, it is imperative to comprehend the physical and chemical attributes of drugs to refine their pharmacokinetic and pharmacodynamic properties.
Tag: PK parameters
Details: Pharmacokinetics encompasses the study of drug disposition within the body, which involves several key parameters, including absorption, distribution, metabolism, and excretion.
Tag: TK and PK
Details: TK is defined as the generation of PK data, either as an integral component in the conduct of nonclinical toxicity studies or in specifically designed supportive studies to assess systemic exposure.
